Cargando…
Effect of Metabolic Syndrome and Individual Components on Colon Cancer Characteristics and Prognosis
Metabolic syndrome (MS) is recognized as a risk factor for colon cancer (CC). However, whether the cluster of metabolic changes that define MS also influence CC prognosis remains unclear. Thus, our aim was to investigate whether the presence of MS or any of the MS individual components could provide...
Autores principales: | Silva, Ana, Pereira, Sofia S., Monteiro, Mariana P., Araújo, António, Faria, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970759/ https://www.ncbi.nlm.nih.gov/pubmed/33747952 http://dx.doi.org/10.3389/fonc.2021.631257 |
Ejemplares similares
-
Establishment of lactate-metabolism-related signature to predict prognosis and immunotherapy response in patients with colon adenocarcinoma
por: Zou, Zhengrong, et al.
Publicado: (2022) -
Metabolic Syndrome and Breast Cancer: Prevalence, Treatment Response, and Prognosis
por: Dong, Shuwen, et al.
Publicado: (2021) -
Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
por: Fernández, Lara P., et al.
Publicado: (2020) -
Integrative Proteo-Genomic Analysis for Recurrent Survival Prognosis in Colon Adenocarcinoma
por: Ai, FeiYan, et al.
Publicado: (2022) -
Cuproplasia characterization in colon cancer assists to predict prognosis and immunotherapeutic response
por: Zhang, Bomiao, et al.
Publicado: (2023)